Faruqi and Faruqui, LLP Logo
Share this page

PetMed Express, Inc. (PETS)

NASDAQ:PETS

Summary

Faruqi & Faruqi, LLP is Investigating PetMed Express, Inc. (PETS) on Behalf of its Shareholders

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ:PETS).

The investigation focuses on whether the Company’s Board of Directors and/or its officers committed mismanagement and breached their fiduciary duties.  On August 23, 2017, Aurelius Value published a report claiming that PetMed, an online veterinary pharmacy, engaged in an extensive online advertising campaign to “aggressively market dangerous painkillers to human opiate addicts and drug users.” 

Take Action

If you currently own PetMed stock and have continuously owned PetMed stock and would like to discuss your legal rights, please visit www.faruqilaw.com/PETS.  You can also contact us by calling Nina Varindani or Stuart Guber toll free at (212) 983-9330 or by sending an e-mail to nvarindani@faruqilaw.com or sguber@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding PetMed’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Request Information

Please tell us about yourself by completing the form below and we will provide you with additional
information on how to join the Action.

  • Company:
    PetMed Express, Inc. (PETS)
  •    

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Stuart J. Guber
Nina Varindani
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330

Email:

Case Details

Date:

  • 08/23/2017

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.